Phaswana P H, Ndumnego O C, Koehler S M, Beyer W, Crafford J E, van Heerden H
Department of Veterinary Tropical Diseases, University of Pretoria, Onderstepoort, 0110, South Africa.
Africa Health Research Institute, K-RITH Tower Building, Umbilo Road, Durban, 4013, South Africa.
Vet Res. 2017 Sep 7;48(1):46. doi: 10.1186/s13567-017-0451-4.
The Sterne live spore vaccine (34F2) is the most widely used veterinary vaccine against anthrax in animals. Antibody responses to several antigens of Bacillus anthracis have been described with a large focus on those against protective antigen (PA). The focus of this study was to evaluate the protective humoral immune response induced by the live spore anthrax vaccine in goats. Boer goats vaccinated twice (week 0 and week 12) with the Sterne live spore vaccine and naive goats were used to monitor the anti-PA and toxin neutralizing antibodies at week 4 and week 17 (after the second vaccine dose) post vaccination. A/J mice were passively immunized with different dilutions of sera from immune and naive goats and then challenged with spores of B. anthracis strain 34F2 to determine the protective capacity of the goat sera. The goat anti-PA ELISA titres indicated significant sero-conversion at week 17 after the second doses of vaccine (p = 0.009). Mice receiving undiluted sera from goats given two doses of vaccine (twice immunized) showed the highest protection (86%) with only 20% of mice receiving 1:1000 diluted sera surviving lethal challenge. The in vitro toxin neutralization assay (TNA) titres correlated to protection of passively immunized A/J mice against lethal infection with the vaccine strain Sterne 34F2 spores using immune goat sera up to a 1:10 dilution (r ≥ 0.522, p = 0.046). This study suggests that the passive mouse protection model could be potentially used to evaluate the protective immune response in livestock animals vaccinated with the current live vaccine and new vaccines.
斯特恩活芽孢疫苗(34F2)是动物中使用最广泛的抗炭疽兽用疫苗。已经描述了针对炭疽芽孢杆菌几种抗原的抗体反应,其中重点关注针对保护性抗原(PA)的反应。本研究的重点是评估活芽孢炭疽疫苗在山羊中诱导的保护性体液免疫反应。用斯特恩活芽孢疫苗对布尔山羊进行两次接种(第0周和第12周),并使用未接种疫苗的山羊,在接种后第4周和第17周(第二次接种疫苗后)监测抗PA和毒素中和抗体。用来自免疫山羊和未接种疫苗山羊的不同稀释度血清对A/J小鼠进行被动免疫,然后用炭疽芽孢杆菌34F2菌株的芽孢进行攻击,以确定山羊血清的保护能力。山羊抗PA ELISA效价表明,在第二次接种疫苗后第17周出现了显著的血清转化(p = 0.009)。接受两剂疫苗(两次免疫)山羊的未稀释血清的小鼠显示出最高的保护率(86%),而接受1:1000稀释血清的小鼠中只有20%在致死性攻击中存活。体外毒素中和试验(TNA)效价与使用免疫山羊血清对被动免疫的A/J小鼠针对疫苗株斯特恩34F2芽孢致死感染的保护作用相关,最高稀释至1:10(r≥0.522,p = 0.046)。本研究表明,被动小鼠保护模型可能潜在地用于评估接种当前活疫苗和新疫苗的家畜的保护性免疫反应。